Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy

Published:2024-08 Issue:8 Volume:5 Page:592-596
ISSN:2666-5018
Container-title:Heart Rhythm O2
language:en
Short-container-title:Heart Rhythm O2

Author:

Hesselson Aaron B.^ORCID,Vaidya Gaurang,Kolodziej Andrew

Publisher

Elsevier BV

Reference8 articles.

1. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation;Abraham;JACC Heart Fail,2018

2. Cardiac contractility modulation in patients with ischemic versus non-ischemic cardiomyopathy: results from the MAINTAINED observational study;Fastner;Int J Cardiol,2021

3. First human implant of the cardiac contractility in patient with dilated cardiomyopathy-related laminopathy;D’Onofrio;HeartRhythm Case Rep,2023

4. Normalization of ventricular function after cardiac contractility modulation in noncompaction cardiomyopathy heterozygous positive for a pathologic TTN gene variant;Hesselson;HeartRhythm Case Rep,2022

5. Cardiac contractility modulation: mechanism of action in heart failure with reduced ejection fraction and beyond;Tschope;Eur J Heart Fail,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3